UBS Group’s Exscientia Plc American Depositary Shares EXAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-92,395
Closed -$451K 10668
2024
Q3
$451K Buy
92,395
+80,626
+685% +$422K ﹤0.01% 5303
2024
Q2
$60K Buy
11,769
+1,974
+20% +$9.73K ﹤0.01% 6547
2024
Q1
$56K Sell
9,795
-3,273
-25% -$20.3K ﹤0.01% 6462
2023
Q4
$83.8K Buy
13,068
+418
+3% +$2.37K ﹤0.01% 6278
2023
Q3
$57.2K Buy
12,650
+6,802
+116% +$44K ﹤0.01% 6212
2023
Q2
$34.6K Sell
5,848
-2,138
-27% -$13.1K ﹤0.01% 6659
2023
Q1
$42.3K Buy
7,986
+878
+12% +$5.96K ﹤0.01% 6572
2022
Q4
$37.9K Buy
7,108
+6,808
+2,269% +$43K ﹤0.01% 7019
2022
Q3
$2K Sell
300
-330
-52% -$3.33K ﹤0.01% 9808
2022
Q2
$7K Buy
630
+230
+58% +$2.74K ﹤0.01% 8556
2022
Q1
$6K Sell
400
-12,119
-97% -$207K ﹤0.01% 9016
2021
Q4
$248K Buy
+12,519
New +$263K ﹤0.01% 5503

Other funds holding EXAI

UBS Group's EXAI Position: Q4 2024 in Review

UBS Group sold out of Exscientia Plc American Depositary Shares (EXAI) in Q4 2024, closing a stake of 92,395 shares — an estimated $451K sold.

UBS Group first reported a position in EXAI in Q4 2021 and held it in 12 quarters. The position peaked at $451K in Q3 2024. 1 fund tracked by Wall St. Rank holds EXAI as of Q4 2024.

  • UBS Group reported no remaining Exscientia Plc American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • UBS Group sold 92,395 Exscientia Plc American Depositary Shares shares in Q4 2024, an estimated $451K.
  • UBS Group first reported a position in Exscientia Plc American Depositary Shares in Q4 2021 and held it in 12 quarters.
  • UBS Group's Exscientia Plc American Depositary Shares position peaked at $451K in Q3 2024.
  • 1 fund tracked by Wall St. Rank held Exscientia Plc American Depositary Shares as of Q4 2024.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.